OSAM
IMGN

O'Shaughnessy Asset Management’s Immunogen Inc IMGN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,620
Closed -$94K – 1396
2021
Q4 		$94K Buy
12,620
+5,115
+68% +$31.8K ﹤0.01% 1131
2021
Q3 		$43K Sell
7,505
-8,547
-53% -$49.4K ﹤0.01% 1707
2021
Q2 		$106K Buy
16,052
+1,893
+13% +$13.2K ﹤0.01% 1283
2021
Q1 		$115K Sell
14,159
-20,858
-60% -$170K ﹤0.01% 1140
2020
Q4 		$226K Buy
35,017
+33,777
+2,724% +$197K 0.01% 788
2020
Q3 		$4K Hold
1,240
– – ﹤0.01% 1538
2020
Q2 		$6K Buy
+1,240
New +$5.27K ﹤0.01% 1358
2020
Q1 		– Sell
-1,915
Closed -$10K – 1904
2019
Q4 		$10K Buy
+1,915
New +$6.5K ﹤0.01% 1314

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

O'Shaughnessy Asset Management's IMGN Position: Q1 2022 in Review

O'Shaughnessy Asset Management sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 12,620 shares — an estimated $94K sold.

O'Shaughnessy Asset Management first reported a position in IMGN in Q4 2019 and held it in 8 quarters. The position peaked at $226K in Q4 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • O'Shaughnessy Asset Management reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 12,620 Immunogen Inc shares in Q1 2022, an estimated $94K.
  • O'Shaughnessy Asset Management first reported a position in Immunogen Inc in Q4 2019 and held it in 8 quarters.
  • O'Shaughnessy Asset Management's Immunogen Inc position peaked at $226K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2022, filed 13 May 2022.